fda glp-1 compounding enforcement september 2025 Omzo Review 2026: Is This Compounded Semaglutide Telehealth Program Legit - Pricing, Context, and What to Verify Before Your First Dose fda glp-1 compounding enforcement september
Description
Nature 577 , 432436 (2020)

Skov J, Dejgaard A, Frkir J, et al

Who can get it: Ozempic and Rybelsus require a diagnosis of type 2 diabetes (although Ozempic can be prescribed off-label for weight loss), while Wegovy requires either a BMI of 30 or a BMI of at least 27 plus another weight-related ailment (like high blood pressure or obstructive sleep apnea)

coverage wouldnt be approved for weight loss, Type 1 diabetes, diabetes prevention, or metabolic syndrome

Adherence to dosing schedule is crucial